ホモシスチン尿症のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Homocystinuria Market Insights, Forecast to 2028

• レポートコード：QY2207E09232 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のホモシスチン尿症の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にホモシスチン尿症の世界市場のxxx％を占める「診断」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のホモシスチン尿症の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのホモシスチン尿症市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのホモシスチン尿症市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ホモシスチン尿症のグローバル主要メーカーには、BASF SE、HUAZHONG PHARMACEUTICAL Co. Ltd.、Pfizer Inc.、MYLAN N.V.、Aeglea BioTherapeutics、Amino GMBH、KAO Corporation、DSM Corporation、Orphan Technologies、Fresenius Kabi AGなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ホモシスチン尿症市場は、種類と用途によって区分されます。世界のホモシスチン尿症市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 診断、治療 【用途別セグメント】 病院、クリニック、診断・画像研究所、学術・研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ホモシスチン尿症製品概要 - 種類別市場（診断、治療） - 用途別市場（病院、クリニック、診断・画像研究所、学術・研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のホモシスチン尿症販売量予測2017-2028 - 世界のホモシスチン尿症売上予測2017-2028 - ホモシスチン尿症の地域別販売量 - ホモシスチン尿症の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ホモシスチン尿症販売量 - 主要メーカー別ホモシスチン尿症売上 - 主要メーカー別ホモシスチン尿症価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（診断、治療） - ホモシスチン尿症の種類別販売量 - ホモシスチン尿症の種類別売上 - ホモシスチン尿症の種類別価格 ・用途別市場規模（病院、クリニック、診断・画像研究所、学術・研究機関、その他） - ホモシスチン尿症の用途別販売量 - ホモシスチン尿症の用途別売上 - ホモシスチン尿症の用途別価格 ・北米市場 - 北米のホモシスチン尿症市場規模（種類別、用途別） - 主要国別のホモシスチン尿症市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのホモシスチン尿症市場規模（種類別、用途別） - 主要国別のホモシスチン尿症市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のホモシスチン尿症市場規模（種類別、用途別） - 主要国別のホモシスチン尿症市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のホモシスチン尿症市場規模（種類別、用途別） - 主要国別のホモシスチン尿症市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのホモシスチン尿症市場規模（種類別、用途別） - 主要国別のホモシスチン尿症市場規模（トルコ、サウジアラビア） ・企業情報 BASF SE、HUAZHONG PHARMACEUTICAL Co. Ltd.、Pfizer Inc.、MYLAN N.V.、Aeglea BioTherapeutics、Amino GMBH、KAO Corporation、DSM Corporation、Orphan Technologies、Fresenius Kabi AG ・産業チェーン及び販売チャネル分析 - ホモシスチン尿症の産業チェーン分析 - ホモシスチン尿症の原材料 - ホモシスチン尿症の生産プロセス - ホモシスチン尿症の販売及びマーケティング - ホモシスチン尿症の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ホモシスチン尿症の産業動向 - ホモシスチン尿症のマーケットドライバー - ホモシスチン尿症の課題 - ホモシスチン尿症の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Homocystinuria Market
The global Homocystinuria market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Diagnosis accounting for % of the Homocystinuria global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Homocystinuria market size is valued at US$ million in 2021, while the North America and Europe Homocystinuria are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Homocystinuria landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Homocystinuria market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Homocystinuria market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Homocystinuria market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Homocystinuria market.
Global Homocystinuria Scope and Market Size
Homocystinuria market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Homocystinuria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Clinics
Diagnostic and Imaging Laboratories
Academic and Research Institutes
Others
By Company
BASF SE
HUAZHONG PHARMACEUTICAL Co. Ltd.
Pfizer Inc.
MYLAN N.V.
Aeglea BioTherapeutics
Amino GMBH
KAO Corporation
DSM Corporation
Orphan Technologies
Fresenius Kabi AG
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Homocystinuria Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Homocystinuria Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic and Imaging Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Homocystinuria Market Perspective (2017-2028)
2.2 Homocystinuria Growth Trends by Region
2.2.1 Homocystinuria Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Homocystinuria Historic Market Size by Region (2017-2022)
2.2.3 Homocystinuria Forecasted Market Size by Region (2023-2028)
2.3 Homocystinuria Market Dynamics
2.3.1 Homocystinuria Industry Trends
2.3.2 Homocystinuria Market Drivers
2.3.3 Homocystinuria Market Challenges
2.3.4 Homocystinuria Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Homocystinuria Players by Revenue
3.1.1 Global Top Homocystinuria Players by Revenue (2017-2022)
3.1.2 Global Homocystinuria Revenue Market Share by Players (2017-2022)
3.2 Global Homocystinuria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Homocystinuria Revenue
3.4 Global Homocystinuria Market Concentration Ratio
3.4.1 Global Homocystinuria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Homocystinuria Revenue in 2021
3.5 Homocystinuria Key Players Head office and Area Served
3.6 Key Players Homocystinuria Product Solution and Service
3.7 Date of Enter into Homocystinuria Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Homocystinuria Breakdown Data by Type
4.1 Global Homocystinuria Historic Market Size by Type (2017-2022)
4.2 Global Homocystinuria Forecasted Market Size by Type (2023-2028)
5 Homocystinuria Breakdown Data by Application
5.1 Global Homocystinuria Historic Market Size by Application (2017-2022)
5.2 Global Homocystinuria Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Homocystinuria Market Size (2017-2028)
6.2 North America Homocystinuria Market Size by Type
6.2.1 North America Homocystinuria Market Size by Type (2017-2022)
6.2.2 North America Homocystinuria Market Size by Type (2023-2028)
6.2.3 North America Homocystinuria Market Share by Type (2017-2028)
6.3 North America Homocystinuria Market Size by Application
6.3.1 North America Homocystinuria Market Size by Application (2017-2022)
6.3.2 North America Homocystinuria Market Size by Application (2023-2028)
6.3.3 North America Homocystinuria Market Share by Application (2017-2028)
6.4 North America Homocystinuria Market Size by Country
6.4.1 North America Homocystinuria Market Size by Country (2017-2022)
6.4.2 North America Homocystinuria Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Homocystinuria Market Size (2017-2028)
7.2 Europe Homocystinuria Market Size by Type
7.2.1 Europe Homocystinuria Market Size by Type (2017-2022)
7.2.2 Europe Homocystinuria Market Size by Type (2023-2028)
7.2.3 Europe Homocystinuria Market Share by Type (2017-2028)
7.3 Europe Homocystinuria Market Size by Application
7.3.1 Europe Homocystinuria Market Size by Application (2017-2022)
7.3.2 Europe Homocystinuria Market Size by Application (2023-2028)
7.3.3 Europe Homocystinuria Market Share by Application (2017-2028)
7.4 Europe Homocystinuria Market Size by Country
7.4.1 Europe Homocystinuria Market Size by Country (2017-2022)
7.4.2 Europe Homocystinuria Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Homocystinuria Market Size (2017-2028)
8.2 Asia-Pacific Homocystinuria Market Size by Type
8.2.1 Asia-Pacific Homocystinuria Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Homocystinuria Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Homocystinuria Market Share by Type (2017-2028)
8.3 Asia-Pacific Homocystinuria Market Size by Application
8.3.1 Asia-Pacific Homocystinuria Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Homocystinuria Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Homocystinuria Market Share by Application (2017-2028)
8.4 Asia-Pacific Homocystinuria Market Size by Region
8.4.1 Asia-Pacific Homocystinuria Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Homocystinuria Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Homocystinuria Market Size (2017-2028)
9.2 Latin America Homocystinuria Market Size by Type
9.2.1 Latin America Homocystinuria Market Size by Type (2017-2022)
9.2.2 Latin America Homocystinuria Market Size by Type (2023-2028)
9.2.3 Latin America Homocystinuria Market Share by Type (2017-2028)
9.3 Latin America Homocystinuria Market Size by Application
9.3.1 Latin America Homocystinuria Market Size by Application (2017-2022)
9.3.2 Latin America Homocystinuria Market Size by Application (2023-2028)
9.3.3 Latin America Homocystinuria Market Share by Application (2017-2028)
9.4 Latin America Homocystinuria Market Size by Country
9.4.1 Latin America Homocystinuria Market Size by Country (2017-2022)
9.4.2 Latin America Homocystinuria Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Homocystinuria Market Size (2017-2028)
10.2 Middle East & Africa Homocystinuria Market Size by Type
10.2.1 Middle East & Africa Homocystinuria Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Homocystinuria Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Homocystinuria Market Share by Type (2017-2028)
10.3 Middle East & Africa Homocystinuria Market Size by Application
10.3.1 Middle East & Africa Homocystinuria Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Homocystinuria Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Homocystinuria Market Share by Application (2017-2028)
10.4 Middle East & Africa Homocystinuria Market Size by Country
10.4.1 Middle East & Africa Homocystinuria Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Homocystinuria Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BASF SE
11.1.1 BASF SE Company Details
11.1.2 BASF SE Business Overview
11.1.3 BASF SE Homocystinuria Introduction
11.1.4 BASF SE Revenue in Homocystinuria Business (2017-2022)
11.1.5 BASF SE Recent Developments
11.2 HUAZHONG PHARMACEUTICAL Co. Ltd.
11.2.1 HUAZHONG PHARMACEUTICAL Co. Ltd. Company Details
11.2.2 HUAZHONG PHARMACEUTICAL Co. Ltd. Business Overview
11.2.3 HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Introduction
11.2.4 HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue in Homocystinuria Business (2017-2022)
11.2.5 HUAZHONG PHARMACEUTICAL Co. Ltd. Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Homocystinuria Introduction
11.3.4 Pfizer Inc. Revenue in Homocystinuria Business (2017-2022)
11.3.5 Pfizer Inc. Recent Developments
11.4 MYLAN N.V.
11.4.1 MYLAN N.V. Company Details
11.4.2 MYLAN N.V. Business Overview
11.4.3 MYLAN N.V. Homocystinuria Introduction
11.4.4 MYLAN N.V. Revenue in Homocystinuria Business (2017-2022)
11.4.5 MYLAN N.V. Recent Developments
11.5 Aeglea BioTherapeutics
11.5.1 Aeglea BioTherapeutics Company Details
11.5.2 Aeglea BioTherapeutics Business Overview
11.5.3 Aeglea BioTherapeutics Homocystinuria Introduction
11.5.4 Aeglea BioTherapeutics Revenue in Homocystinuria Business (2017-2022)
11.5.5 Aeglea BioTherapeutics Recent Developments
11.6 Amino GMBH
11.6.1 Amino GMBH Company Details
11.6.2 Amino GMBH Business Overview
11.6.3 Amino GMBH Homocystinuria Introduction
11.6.4 Amino GMBH Revenue in Homocystinuria Business (2017-2022)
11.6.5 Amino GMBH Recent Developments
11.7 KAO Corporation
11.7.1 KAO Corporation Company Details
11.7.2 KAO Corporation Business Overview
11.7.3 KAO Corporation Homocystinuria Introduction
11.7.4 KAO Corporation Revenue in Homocystinuria Business (2017-2022)
11.7.5 KAO Corporation Recent Developments
11.8 DSM Corporation
11.8.1 DSM Corporation Company Details
11.8.2 DSM Corporation Business Overview
11.8.3 DSM Corporation Homocystinuria Introduction
11.8.4 DSM Corporation Revenue in Homocystinuria Business (2017-2022)
11.8.5 DSM Corporation Recent Developments
11.9 Orphan Technologies
11.9.1 Orphan Technologies Company Details
11.9.2 Orphan Technologies Business Overview
11.9.3 Orphan Technologies Homocystinuria Introduction
11.9.4 Orphan Technologies Revenue in Homocystinuria Business (2017-2022)
11.9.5 Orphan Technologies Recent Developments
11.10 Fresenius Kabi AG
11.10.1 Fresenius Kabi AG Company Details
11.10.2 Fresenius Kabi AG Business Overview
11.10.3 Fresenius Kabi AG Homocystinuria Introduction
11.10.4 Fresenius Kabi AG Revenue in Homocystinuria Business (2017-2022)
11.10.5 Fresenius Kabi AG Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Homocystinuria Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Homocystinuria Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Homocystinuria Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Homocystinuria Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Homocystinuria Market Share by Region (2017-2022)
Table 8. Global Homocystinuria Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Homocystinuria Market Share by Region (2023-2028)
Table 10. Homocystinuria Market Trends
Table 11. Homocystinuria Market Drivers
Table 12. Homocystinuria Market Challenges
Table 13. Homocystinuria Market Restraints
Table 14. Global Homocystinuria Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Homocystinuria Revenue Share by Players (2017-2022)
Table 16. Global Top Homocystinuria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Homocystinuria as of 2021)
Table 17. Ranking of Global Top Homocystinuria Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Homocystinuria Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Homocystinuria Product Solution and Service
Table 21. Date of Enter into Homocystinuria Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Homocystinuria Revenue Market Share by Type (2017-2022)
Table 25. Global Homocystinuria Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Homocystinuria Revenue Market Share by Type (2023-2028)
Table 27. Global Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Homocystinuria Revenue Share by Application (2017-2022)
Table 29. Global Homocystinuria Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Homocystinuria Revenue Share by Application (2023-2028)
Table 31. North America Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Homocystinuria Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Homocystinuria Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Homocystinuria Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Homocystinuria Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Homocystinuria Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Homocystinuria Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Homocystinuria Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Homocystinuria Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Homocystinuria Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Homocystinuria Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Homocystinuria Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Homocystinuria Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Homocystinuria Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Homocystinuria Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Homocystinuria Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Homocystinuria Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Homocystinuria Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Homocystinuria Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Homocystinuria Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Homocystinuria Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Homocystinuria Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Homocystinuria Market Size by Country (2023-2028) & (US$ Million)
Table 61. BASF SE Company Details
Table 62. BASF SE Business Overview
Table 63. BASF SE Homocystinuria Product
Table 64. BASF SE Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 65. BASF SE Recent Developments
Table 66. HUAZHONG PHARMACEUTICAL Co. Ltd. Company Details
Table 67. HUAZHONG PHARMACEUTICAL Co. Ltd. Business Overview
Table 68. HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Product
Table 69. HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 70. HUAZHONG PHARMACEUTICAL Co. Ltd. Recent Developments
Table 71. Pfizer Inc. Company Details
Table 72. Pfizer Inc. Business Overview
Table 73. Pfizer Inc. Homocystinuria Product
Table 74. Pfizer Inc. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 75. Pfizer Inc. Recent Developments
Table 76. MYLAN N.V. Company Details
Table 77. MYLAN N.V. Business Overview
Table 78. MYLAN N.V. Homocystinuria Product
Table 79. MYLAN N.V. Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 80. MYLAN N.V. Recent Developments
Table 81. Aeglea BioTherapeutics Company Details
Table 82. Aeglea BioTherapeutics Business Overview
Table 83. Aeglea BioTherapeutics Homocystinuria Product
Table 84. Aeglea BioTherapeutics Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 85. Aeglea BioTherapeutics Recent Developments
Table 86. Amino GMBH Company Details
Table 87. Amino GMBH Business Overview
Table 88. Amino GMBH Homocystinuria Product
Table 89. Amino GMBH Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 90. Amino GMBH Recent Developments
Table 91. KAO Corporation Company Details
Table 92. KAO Corporation Business Overview
Table 93. KAO Corporation Homocystinuria Product
Table 94. KAO Corporation Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 95. KAO Corporation Recent Developments
Table 96. DSM Corporation Company Details
Table 97. DSM Corporation Business Overview
Table 98. DSM Corporation Homocystinuria Product
Table 99. DSM Corporation Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 100. DSM Corporation Recent Developments
Table 101. Orphan Technologies Company Details
Table 102. Orphan Technologies Business Overview
Table 103. Orphan Technologies Homocystinuria Product
Table 104. Orphan Technologies Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 105. Orphan Technologies Recent Developments
Table 106. Fresenius Kabi AG Company Details
Table 107. Fresenius Kabi AG Business Overview
Table 108. Fresenius Kabi AG Homocystinuria Product
Table 109. Fresenius Kabi AG Revenue in Homocystinuria Business (2017-2022) & (US$ Million)
Table 110. Fresenius Kabi AG Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Homocystinuria Market Share by Type: 2021 VS 2028
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Homocystinuria Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic and Imaging Laboratories Case Studies
Figure 8. Academic and Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Homocystinuria Report Years Considered
Figure 11. Global Homocystinuria Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Homocystinuria Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Homocystinuria Market Share by Region: 2021 VS 2028
Figure 14. Global Homocystinuria Market Share by Players in 2021
Figure 15. Global Top Homocystinuria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Homocystinuria as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Homocystinuria Revenue in 2021
Figure 17. North America Homocystinuria Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Homocystinuria Market Size Market Share by Type (2017-2028)
Figure 19. North America Homocystinuria Market Size Market Share by Application (2017-2028)
Figure 20. North America Homocystinuria Market Size Share by Country (2017-2028)
Figure 21. United States Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Homocystinuria Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Homocystinuria Market Size Market Share by Type (2017-2028)
Figure 25. Europe Homocystinuria Market Size Market Share by Application (2017-2028)
Figure 26. Europe Homocystinuria Market Size Share by Country (2017-2028)
Figure 27. Germany Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Homocystinuria Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Homocystinuria Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Homocystinuria Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Homocystinuria Market Size Share by Region (2017-2028)
Figure 37. China Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Homocystinuria Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Homocystinuria Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Homocystinuria Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Homocystinuria Market Size Share by Country (2017-2028)
Figure 47. Mexico Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Homocystinuria Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Homocystinuria Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Homocystinuria Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Homocystinuria Market Size Share by Country (2017-2028)
Figure 53. Turkey Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Homocystinuria Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. BASF SE Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 57. HUAZHONG PHARMACEUTICAL Co. Ltd. Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 58. Pfizer Inc. Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 59. MYLAN N.V. Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 60. Aeglea BioTherapeutics Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 61. Amino GMBH Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 62. KAO Corporation Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 63. DSM Corporation Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 64. Orphan Technologies Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 65. Fresenius Kabi AG Revenue Growth Rate in Homocystinuria Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---